MedWatch

Smith & Nephew revenue better than expected, but operating result disappoints

UK-based medtech firm Smith & Nephew, which competes with Coloplast, has reported a revenue that surpasses analysts' expectations, but the operating result is underwhelming.

Photo: Stine Rasmussen/JPA

Smith & Nephew, a UK-based company which makes products including bandages and creams, has released its half-year report for 2021.

The report showed a revenue that was better than expected, but a disappointing operating result, Bloomberg News reports after collecting consensus data.

Read the whole article

Get 14 days free access.
No credit card required.

An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

CHMP recommends nine new drugs, rejects one

Roche and Biogen are among the companies that have received recommendation for approval from the European Medicines Agency's committee (CHMP) at its September meeting. One Pfizer drug was the sole candidate to be rejected.

CEO at WSA: No clarity on EQT exit plans yet

The time horizon for the venture fund EQT's investment in WS Audiology should be ending soon, but according to Group CEO Eric Bernard, there is no clarity on when the potential changes might occur.

Further reading

Related articles

Trial banner

Latest news

See all jobs